Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of anti-thymocyte globulin: Examination of the role of the Fas-Fas-L interaction

British Journal of Haematology

Volumn 111, Issue 4, 2000, Pages 1164-1169

  Killick, S B ^a,b   Cox, C V ^a   Marsh, J C W ^a   Gordon Smith, E C ^a   Gibson, F M ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Anti thymocyte globulin; Aplastic anaemia; Apoptosis; Fas

Indexed keywords

7 AMINODACTINOMYCIN; CD34 ANTIGEN; FAS ANTIGEN; FAS LIGAND; THYMOCYTE ANTIBODY;

ANTIGEN EXPRESSION; APLASTIC ANEMIA; APOPTOSIS; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ANTIGENS, CD34; ANTIGENS, CD95; APOPTOSIS; CASE-CONTROL STUDIES; FAS LIGAND PROTEIN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOPHENOTYPING; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 0034487601     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02485.x     Document Type: Article

References (22)

1. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): A report of the EBMT SAA working party
2. Selection of patients for bone marrow transplantation in severe aplastic anemia
3. Anti-thymocyte globulin treatment in patients with aplastic anemia: A prospective randomized trial
4. Effect of antilymphocyte globulin on granulocyte precursors in aplastic anaemia
5. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine
6. Induction of Fas (Apo-1. CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins
7. The role of CD45RO in antithymocyte globulin's stimulation of primitive haemopoietic cells
8. Differentiation of normal marrow and HL60 cells induced by antithymocyte globulin
9. In vitro anti-thymocyte globulin stimulation of hemopoietic stem cells: Correlation with clinical response in patients with aplastic anemia and myelodysplasia
10. + cells in aplastic anemia and myelodysplasia
11. + cells of patients with aplastic anaemia
12. + human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro
13. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of anti-thymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: A report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party
14. Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity
15. Apoptosis regulated by a death factor and its receptor: Fas ligand and Fas
16. Long-term outcome of aplastic anemia in adults treated with anti-thymocyte globulin: Comparison with bone marrow transplantation
17. Increased apoptosis in aplastic anemia bone marrow progenitor cells: Possible pathophysiologic significance
18. The use of 7-amino actinomycin D in identifying apoptosis: Simplicity of use and broad spectrum of application compared with other techniques
19. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes
20. Intensive immunosuppression with anti-thymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia
21. Pathophysiology and treatment of aplastic anaemia, consensus document of an international expert meeting
22. A multicenter trial of anti-thymocyte globulin in aplastic anemia and related diseases